0 Fresenius Medical Care AG & Co. Analyst Ratings, Earnings, Dividends and Insider Trades | $FMS | NYSE:FMS | Analyst Ratings Network Follow @RatingsNetwork Find a Company: Login Stock Ratings Today's Ratings U.S. Analyst Ratings (NYSE and NASDAQ) All U.S. Ratings Upgrades Downgrades New Coverage Price Target Changes Rating Reiterations Canadian Analyst Ratings (TSE and TSV) U.K. Analyst Ratings (LSE) Australian Analyst Ratings (ASX) Lookup Company Ratings Free Ratings Newsletter ARN Daily Premium ($) RatingsDB ($) Stock Ratings App Earnings Today's Announcements Tomorrow's Announcements Free Earnings Newsletter CER Wire Premium ($) Lookup Company Earnings Dividends Insider Trades About Contact Fresenius Medical Care AG & Co. Company Profile (NYSE:FMS) Tweet Analyst RatingsEarningsDividendsInsider TradesCompany ProfileSocial ActivityToday's Chart Consensus Ratings for Fresenius Medical Care AG & Co. (NYSE:FMS) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.Ratings Breakdown: 2 Sell Rating(s), 7 Hold Rating(s), 2 Buy Rating(s)Consensus Rating:Hold (Score: 2.00)Consensus Price Target: $39.50 (17.07% upside) Analysts' Ratings History for Fresenius Medical Care AG & Co. (NYSE:FMS) Show: All Ratings For This Stock Only the Most Recent Rating From Each Brokerage DateFirmActionRatingPrice TargetDetailsShare3/5/2014Berenberg BankDowngradeBuy -> HoldView 3/4/2014HSBCDowngradeNeutral -> UnderweightView 2/26/2014UBS AGDowngradeBuy -> NeutralView 1/8/2014JPMorgan Chase & Co.UpgradeUnderweight -> NeutralView 12/2/2013Morgan StanleyUpgradeEqual Weight -> OverweightView 9/27/2013Deutsche BankDowngradeHold -> Sell$44.00View 8/6/2013Societe GeneraleDowngradeBuy -> HoldView 8/2/2013Feltl & Co.Lower Price TargetHold$36.00 -> $35.00View 7/15/2013Jefferies GroupDowngradeBuy -> HoldView 7/3/2013BNP ParibasDowngradeOutperform -> NeutralView 6/10/2013BarclaysUpgradeEqual Weight -> OverweightView 3/7/2013RBC CapitalDowngradeOutperform -> Sector Perform$36.00View 1/31/2013Goldman SachsDowngradeBuy -> NeutralView 1/16/2013UBS AGUpgradeNeutral -> BuyView 1/14/2013HSBCUpgradeNeutral -> OverweightView 1/10/2013Credit SuisseDowngradeOutperform -> NeutralView 12/6/2012Goldman SachsUpgradeBuyView 11/12/2012Goldman SachsUpgradeBuy -> Conviction BuyView 11/1/2012Bank of AmericaDowngradeBuy -> NeutralView 11/1/2012Piper JaffrayDowngradeOverweight -> NeutralView 10/11/2012HSBCDowngradeOverweight -> NeutralView 9/18/2012JPMorgan Chase & Co.DowngradeNeutral -> UnderweightView 9/12/2012Goldman SachsDowngradeConviction Buy -> BuyView 8/31/2012HSBCInitiated CoverageOverweightView 8/31/2012Societe GeneraleInitiated CoverageBuyView 8/7/2012Credit SuisseInitiated CoverageOutperformView 8/2/2012HSBCDowngradeOverweight -> NeutralView 7/20/2012Jefferies GroupDowngradeBuy -> HoldView 4/24/2012HSBCInitiated CoverageOverweightView 4/17/2012Robert W. BairdInitiated CoverageNeutralView (Data available from 3/10/2012 forward) Earnings History for Fresenius Medical Care AG & Co. (NYSE:FMS)DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetailsShare2/25/2014Q4$0.53$0.58ViewN/AView 11/5/2013$0.45$0.47ViewN/AView 7/30/2013$0.46$0.43ViewN/AView (Data available from 1/1/2011 forward) Dividend History for Fresenius Medical Care AG & Co. (NYSE:FMS)AnnouncedPeriodAmountEx-Dividend DateRecord DatePayable DateShare5/14/2013annual$0.495/14/20135/16/20135/28/2013 (Data available from 1/1/2013 forward) Insider Trading History for Fresenius Medical Care AG & Co. (NYSE:FMS)No insider trades for this company have been tracked by Analyst Ratings Network About Fresenius Medical Care AG & Co. Fresenius Medical Care AG & Co KGaA is a Germany-based holding and kidney dialysis company, operating in the fields of dialysis products and dialysis services. Its dialysis business is vertically integrated, providing dialysis treatment at its own dialysis clinics and supplying these clinics with a range of products. In addition, the Company sells dialysis products to other dialysis service providers. The Company operates in two business segments: North America and International. The North America segment consists of Renal Therapy Group and Fresenius Medical Services. The International segment consists of Europe and Latin America and one Asia-Pacific unit. During the year ended December 31, 2010, the Company's subsidiary, U.S. Vascular Access Holdings, LLC, completed the acquisition of National Vascular Care Inc.; it acquired a total of 168 existing clinics, and acquired Gambro AB's peritoneal dialysis (PD) business. The Company has a total of 1000 subsidiaries worldwide. Industry, Sector and Symbol: Sector: N/A Industry: N/A Sub-Industry: N/A Exchange: NYSE Symbol: FMS CUSIP: Key Metrics: Previous Close: $33.6950 Day Moving Average: $35.4121200 Day Moving Average: $33.9641 P/E Ratio: 18.46P/E Growth: 2.34Market Cap: $20.342BCurrent Quarter EPS Consensus Estimate: $1.81 EPS Additional Links: View FMS on Google FinanceView FMS on Yahoo FinanceView FMS's Company Profile on ReutersSearch for Fresenius Medical Care AG & Co. on Google Fresenius Medical Care AG & Co. (NYSE:FMS) Chart for Monday, March, 10, 2014 (Chart Provided by Yahoo Finance) © Analyst Ratings Network 2010-2014. All rights reserved. Contact | Terms and Conditions | Subscribe | Subscribe Earnings | Google+ Analyst Ratings Network does not provide financial advice and does not issue recommendations or offers to buy or sell any security. Learn more.